Yoav Mazor

1.4k total citations
48 papers, 1.0k citations indexed

About

Yoav Mazor is a scholar working on Surgery, Rheumatology and Genetics. According to data from OpenAlex, Yoav Mazor has authored 48 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 15 papers in Rheumatology and 15 papers in Genetics. Recurrent topics in Yoav Mazor's work include Inflammatory Bowel Disease (15 papers), Pelvic floor disorders treatments (14 papers) and Gastrointestinal motility and disorders (12 papers). Yoav Mazor is often cited by papers focused on Inflammatory Bowel Disease (15 papers), Pelvic floor disorders treatments (14 papers) and Gastrointestinal motility and disorders (12 papers). Yoav Mazor collaborates with scholars based in Israel, Australia and Germany. Yoav Mazor's co-authors include Yehuda Chowers, Shomron Ben‐Horin, Uri Kopylov, Rami Eliakim, Allison Malcolm, Michael Jones, John Kellow, Henit Yanai, Iris Dotan and Yulia Ron and has published in prestigious journals such as Gastroenterology, Pain and The American Journal of Gastroenterology.

In The Last Decade

Yoav Mazor

45 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoav Mazor Israel 17 610 521 300 259 171 48 1.0k
Mark R. Fleisher United States 10 674 1.1× 520 1.0× 429 1.4× 220 0.8× 99 0.6× 17 1.2k
Laurence Picon France 16 1.0k 1.7× 800 1.5× 341 1.1× 452 1.7× 107 0.6× 43 1.5k
Kathleen G. Lomax United States 17 1.6k 2.6× 1.3k 2.5× 342 1.1× 660 2.5× 116 0.7× 59 2.0k
C. Petruzziello Italy 23 787 1.3× 570 1.1× 96 0.3× 536 2.1× 67 0.4× 53 1.1k
Yuga Komaki Japan 16 359 0.6× 342 0.7× 227 0.8× 264 1.0× 77 0.5× 47 882
J. Mark Farrant United Kingdom 13 753 1.2× 816 1.6× 169 0.6× 839 3.2× 142 0.8× 18 1.7k
Richmond Sy Canada 8 786 1.3× 1.1k 2.1× 271 0.9× 702 2.7× 55 0.3× 17 1.7k
Anna Ramírez‐Morros Spain 12 695 1.1× 521 1.0× 158 0.5× 412 1.6× 29 0.2× 32 1.1k
Nathaniel Wisch United States 12 751 1.2× 503 1.0× 168 0.6× 311 1.2× 92 0.5× 24 1.2k
Antoine Blain France 9 1.1k 1.8× 868 1.7× 200 0.7× 769 3.0× 30 0.2× 17 1.6k

Countries citing papers authored by Yoav Mazor

Since Specialization
Citations

This map shows the geographic impact of Yoav Mazor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoav Mazor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoav Mazor more than expected).

Fields of papers citing papers by Yoav Mazor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoav Mazor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoav Mazor. The network helps show where Yoav Mazor may publish in the future.

Co-authorship network of co-authors of Yoav Mazor

This figure shows the co-authorship network connecting the top 25 collaborators of Yoav Mazor. A scholar is included among the top collaborators of Yoav Mazor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoav Mazor. Yoav Mazor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mazor, Yoav, et al.. (2025). Characterization of Anal Slow Waves and Ultraslow Waves in Patients With Constipation and Healthy Subjects. Neurogastroenterology & Motility. 37(6). e70006–e70006.
2.
Cohen, Daniel L., et al.. (2025). Trainees’ Exposure to the Field of Neurogastroenterology and Motility in Internal Medicine and General Surgery Residency Programs. Neurogastroenterology & Motility. 37(6). e70016–e70016. 1 indexed citations
3.
Mazor, Yoav, Michael Jones, Anastasia Ejova, et al.. (2024). Prospective Evaluation of Autonomic Function and Intestinal Blood Flow in Health and Irritable Bowel Syndrome Shows Differences Limited to Patients With Constipation Predominance. Neurogastroenterology & Motility. 37(2). e14975–e14975.
4.
Koifman, Eduard, et al.. (2024). Long term persistence and risk factors for anorectal symptoms following low anterior resection for rectal cancer. BMC Gastroenterology. 24(1). 31–31. 3 indexed citations
5.
Mazor, Yoav, et al.. (2024). Management After Obstetric Anal Sphincter Injury: Anorectal Manometry and Symptoms Predict Long-Term Fecal Incontinence. The American Journal of Gastroenterology. 120(4). 864–872. 1 indexed citations
6.
Mazor, Yoav, et al.. (2023). The patient with obstructed defecatory symptoms: Management differs considerably between physicians and surgeons. Neurogastroenterology & Motility. 35(8). e14592–e14592. 2 indexed citations
7.
Caspi, Yaki, et al.. (2022). Structural plasticity of axon initial segment in spinal cord neurons underlies inflammatory pain. Pain. 164(6). 1388–1401. 5 indexed citations
8.
Mazor, Yoav, Gillian Prott, Michael Jones, et al.. (2022). Flatus Incontinence and Fecal Incontinence: A Case-Control Study. Diseases of the Colon & Rectum. 66(4). 591–597. 1 indexed citations
9.
Mazor, Yoav, et al.. (2020). Factors Associated With Response to Anorectal Biofeedback Therapy in Patients With Fecal Incontinence. Clinical Gastroenterology and Hepatology. 19(3). 492–502.e5. 14 indexed citations
10.
Mazor, Yoav, et al.. (2019). Risk Factors for Low Bone Density in Inflammatory Bowel Disease: Use of Glucocorticoids, Low Body Mass Index, and Smoking. Digestive Diseases. 37(4). 284–290. 20 indexed citations
11.
Mazor, Yoav, et al.. (2018). Long‐term outcome of anorectal biofeedback for treatment of fecal incontinence. Neurogastroenterology & Motility. 30(8). e13389–e13389. 17 indexed citations
12.
Klein, Amir, Yoav Mazor, Amir Karban, et al.. (2016). Early histological findings may predict the clinical phenotype in Crohn’s colitis. United European Gastroenterology Journal. 5(5). 694–701. 17 indexed citations
13.
Yanai, Henit, Lev Lichtenstein, Amit Assa, et al.. (2014). Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab. Clinical Gastroenterology and Hepatology. 13(3). 522–530.e2. 236 indexed citations
14.
Shpack, Nir, Tamar Brosh, Yoav Mazor, et al.. (2014). Long- and short-term effects of headgear traction with and without the maxillary second molars. American Journal of Orthodontics and Dentofacial Orthopedics. 146(4). 467–476. 16 indexed citations
15.
Koifman, Eduard, Amir Karban, Yoav Mazor, et al.. (2013). Thiopurine Effectiveness in Patients with Crohnʼs Disease. Inflammatory Bowel Diseases. 19(8). 1639–1644. 16 indexed citations
16.
Mazor, Yoav, Eduard Koifman, Yehuda Chowers, et al.. (2013). Risk Factors for Serious Adverse Effects of Thiopurines in Patients with Crohn’s Disease. Current Drug Safety. 8(3). 181–185. 25 indexed citations
17.
Kopylov, Uri, Yoav Mazor, Miri Yavzori, et al.. (2011). Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies. Inflammatory Bowel Diseases. 18(9). 1628–1633. 74 indexed citations
18.
Mazor, Yoav, Itay Maza, Shomron Ben‐Horin, et al.. (2011). Prediction of disease complication occurrence in Crohn's disease using phenotype and genotype parameters at diagnosis. Journal of Crohn s and Colitis. 5(6). 592–597. 43 indexed citations
19.
Mazor, Yoav, Amir Karban, Batia Weiss, et al.. (2010). Granulomas in Crohn's disease: Are newly discovered genetic variants involved?. Journal of Crohn s and Colitis. 4(4). 438–443. 16 indexed citations
20.
Nadir, Yona, et al.. (2006). A fatal case of enoxaparin induced skin necrosis and thrombophilia. European Journal Of Haematology. 77(2). 166–168. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark R. Fleisher Breakdown of academic impact, for papers by Laurence Picon Breakdown of academic impact, for papers by Kathleen G. Lomax Breakdown of academic impact, for papers by C. Petruzziello Breakdown of academic impact, for papers by Yuga Komaki Breakdown of academic impact, for papers by J. Mark Farrant Breakdown of academic impact, for papers by Richmond Sy Breakdown of academic impact, for papers by Anna Ramírez‐Morros Breakdown of academic impact, for papers by Nathaniel Wisch Breakdown of academic impact, for papers by Antoine Blain
Rankless by CCL
2026